Company / Shareholders' Equity
ENvue Medical, Inc. Shareholders' Equity History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Shareholders' Equity
$627.0K
FY2025
5-year range
$627.0K / $6.3M
FY2021-FY2025
Trend
-84.3%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Shareholders' Equity has fluctuated over the past 10 years, ranging from -$6M in FY2016 to $6M in FY2022.
Based on SEC 10-K filings.
$627,000 in FY2025 with a 5-year CAGR of -14.2%.
Declined from $3M to $627,000 over the past 2 years.
Shareholders' Equity over time
Growth rates
- 3-Year CAGR
- -53.7%
- 5-Year CAGR
- -14.2%
- 10-Year CAGR
- -
Key checks
Key Insights
- 5-year CAGR of -14.2%, indicating a declining trend.
- In FY2025, shareholders' equity decreased 84.3% year-over-year.
- Peak shareholders' equity was recorded in FY2022.
- Lowest shareholders' equity in the period was in FY2016.
Company context
Key Data Points
- Altman Z-Score -0.19 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Shareholders' EquityValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $627.0K | -84.3% |
| FY2024 | $4.0M | +23.4% |
| FY2023 | $3.2M | -48.8% |
| FY2022 | $6.3M | +163.7% |
| FY2021 | $2.4M | +77.6% |
| FY2020 | $1.3M | +191.1% |
| FY2019 | $463.0K | -87.3% |
| FY2018 | $3.6M | +0.0% |
| FY2017 | $3.6M | +164.7% |
| FY2016 | -$5.6M | +0.0% |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026